GB919115107A
GB9115107D0
(en)
|
1991-07-12 |
1991-07-12 |
Pharmaceutical agents
|
IL10009191A
IL100091A
(en)
|
1990-12-12 |
1991-11-19 |
Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation
|
CA002319308A
CA2319308C
(en)
|
1990-12-12 |
1991-11-22 |
Pharmaceutical agents
|
CA002056066A
CA2056066C
(en)
|
1990-12-12 |
1991-11-22 |
A physical form of n-[4-[5-(cyclopentyloxycarbony)amino-1-methylindol-3yl-methy1]-3-methoxybenzoy1]-2-methlbenzenesulphonamide, processes for its preparation and compositions containing it
|
HU913865A
HU213211B
(en)
|
1990-12-12 |
1991-12-09 |
Process for producing new physical modification of n-/4-(5-(cyclopentyl oxycarbonyl)amino-1-methylindol-3-yl-methyl)-3-methoxybenzoyl/-2-methyl benzenesulphonamide and pharmaceutical compositions comprising the same
|
MX9102473A
MX9102473A
(en)
|
1990-12-12 |
1991-12-10 |
PHARMACEUTICAL AGENTS.
|
TW080109698A
TW276181B
(en)
|
1990-12-12 |
1991-12-10 |
|
AU88994/91A
AU656157B2
(en)
|
1990-12-12 |
1991-12-11 |
Pharmaceutical agents
|
DK91311504.4T
DK0490648T3
(en)
|
1990-12-12 |
1991-12-11 |
Pharmaceuticals
|
APAP/P/1991/000340A
AP285A
(en)
|
1990-12-12 |
1991-12-11 |
Pharmaceutical composition comprising a particular pysical form of a heterocyclic amide derivative.
|
GB9126354A
GB2251791B
(en)
|
1990-12-12 |
1991-12-11 |
Pharmaceutical compositions containing benzenesulphonamides
|
DE69115229T
DE69115229T2
(en)
|
1990-12-12 |
1991-12-11 |
Drug.
|
SK3756-91A
SK279813B6
(en)
|
1990-12-12 |
1991-12-11 |
Pharmaceutical composition, process for preparation thereof, and intermediate usable therein
|
AT91311504T
ATE131048T1
(en)
|
1990-12-12 |
1991-12-11 |
DRUG.
|
PH43619A
PH30928A
(en)
|
1990-12-12 |
1991-12-11 |
Pharmaceutical agents.
|
ES91311504T
ES2079589T3
(en)
|
1990-12-12 |
1991-12-11 |
PHARMACEUTICAL AGENTS.
|
FI915826A
FI101193B
(en)
|
1990-12-12 |
1991-12-11 |
A process for the preparation of a pharmaceutical composition comprising a physical form of N-? 4-?
|
MYPI91002302A
MY106315A
(en)
|
1990-12-12 |
1991-12-11 |
Pharmaceutical agents
|
EP91311504A
EP0490648B1
(en)
|
1990-12-12 |
1991-12-11 |
Pharmaceutical agents
|
DE4140858A
DE4140858A1
(en)
|
1990-12-12 |
1991-12-11 |
PHARMACEUTICAL AGENTS
|
KR1019910022917A
KR0183027B1
(en)
|
1990-12-12 |
1991-12-11 |
Pharmaceutical agents
|
GB9418154A
GB2280606B
(en)
|
1990-12-12 |
1991-12-11 |
Physical forms of benzenesulphonamides
|
CS913756A
CZ283181B6
(en)
|
1990-12-12 |
1991-12-11 |
Pharmaceutical preparation, process of its preparation, process for preparing active component thereof and intermediate for such process
|
SU5010340/14A
RU2106140C1
(en)
|
1990-12-12 |
1991-12-11 |
Pharmaceutical composition, method for its obtaining, physical form of n-;4-;5-(cyclopentyloxycarbonyl)amino-1-methilindol-3-il-methyl-3- -methoxybenzoil
|
CN91111566A
CN1043405C
(en)
|
1990-12-12 |
1991-12-11 |
Pharmaceutical agents
|
FR9115366A
FR2670488B1
(en)
|
1990-12-12 |
1991-12-11 |
PHARMACEUTICAL COMPOSITION CONTAINING A PARTICULAR PHYSICAL FORM OF A HETEROCYCLIC AMIDE AND METHOD FOR PREPARING THE SAME.
|
BE9101127A
BE1004229A5
(en)
|
1990-12-12 |
1991-12-11 |
PHARMACEUTICAL AGENTS.
|
JP3327783A
JP2585495B2
(en)
|
1990-12-12 |
1991-12-11 |
Medicine
|
US07/805,421
US5319097A
(en)
|
1990-12-12 |
1991-12-11 |
Pharmaceutical agents
|
UA5010340A
UA27711C2
(en)
|
1991-07-12 |
1991-12-11 |
Pharmaceutical composition useful in the treatment of diseases in which leukotrienes are implicated
|
IE431091A
IE75348B1
(en)
|
1990-12-12 |
1991-12-11 |
Pharmaceutical agents
|
ITMI913324A
IT1256282B
(en)
|
1990-12-12 |
1991-12-11 |
PHARMACEUTICAL COMPOSITION THAT INCLUDES A PARTICULAR PHYSICAL FORM OF A DERIVATIVE OF A HETEROCYCLIC STARCH
|
NZ240939A
NZ240939A
(en)
|
1990-12-12 |
1991-12-11 |
A physical form of n-[4-[5-(cyclopentyloxycarbonyl)-amino-1-methylindol-3-yl- methyl]-3-methoxybenzoyl]-2-methyl-benzenesulphonamide with particular ir spectrum
|
US08/116,781
US5482963A
(en)
|
1990-12-12 |
1993-09-03 |
Pharmaceutical agents useful as leukotriene antagonists
|
US08/403,132
US5504216A
(en)
|
1990-12-12 |
1995-03-13 |
Method for reparing an amorphous sulfonamide
|
US08/474,191
US5612367A
(en)
|
1990-12-12 |
1995-06-07 |
Method of enhancing bioavailability of pharmaceutical agents
|
HU95P/P00181P
HU211126A9
(en)
|
1990-12-12 |
1995-06-09 |
Pharmaceutical agents
|
GR950403190T
GR3018318T3
(en)
|
1990-12-12 |
1995-12-07 |
Pharmaceutical agents.
|
KR1019960036692A
KR100207802B1
(en)
|
1990-12-12 |
1996-08-30 |
N- [4(5-cyclopentyloxycarbonyl) amino-1-methylindol-3-yl-methyl]-3-methoxybenzoyl]-2-methylbenzenesulfoneamide and the process for the preparation thereof
|
FI972528A
FI106021B
(en)
|
1990-12-12 |
1997-06-13 |
Process for preparing a physical form of N-[4-[5- (cyclopentyloxycarbonyl)amino-1-methylindol-3-ylmethyl]-3- methoxybenzoyl]-2-methylbenzenesulphonamide
|
HK81597A
HK81597A
(en)
|
1990-12-12 |
1997-06-19 |
Physical forms of benzene-sulphonamides
|
HK81397A
HK81397A
(en)
|
1990-12-12 |
1997-06-19 |
Pharmaceutical compositions containing benzene-sulphonamides
|
FI980376A
FI980376A
(en)
|
1990-12-12 |
1998-02-18 |
Pharmaceutical composition containing a physical form of N- / 4- / 5- (cyclopentyloxycarbonyl) amino-1-methylindol-3-ylmethyl / -3-methoxybenzoyl / -2-methylbenzenesulfonamide
|
SK664-98A
SK279814B6
(en)
|
1990-12-12 |
1998-05-20 |
Method for the preparation of a n-[4-[5-(cyclopentyloxycarbonyl)- -amino-1-methylindol-3-yl-methyl]-3-methoxybenzoyl]-2-methyl- -benzenesulphonamide, and intermediate usable for said method
|
US09/114,225
US5993859A
(en)
|
1990-12-12 |
1998-07-13 |
Pharmaceutical agents
|
CN98121369A
CN1105705C
(en)
|
1990-12-12 |
1998-10-14 |
Preparation of heterocyclic amide derivative with specific physical status
|
US09/447,414
US6143775A
(en)
|
1990-12-12 |
1999-11-23 |
Process for preparing pharmaceutical composition containing a heterocyclic amide
|